Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 13, 2020 01:55 ET | Source: Karolinska Development AB (publ)

Bokslutskommuniké för januari – december 2019

STOCKHOLM – den 13 februari 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) publicerar idag sin bokslutskommuniké för januari - december 2019 med det bästa resultatet för helåret i bolagets...
February 13, 2020 01:55 ET | Source: Karolinska Development AB (publ)

Year-End Report - January-December 2019

STOCKHOLM – 13 February 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Year-End Report - January-December 2019 with the company’s best ever full-year result. The full...
January 30, 2020 07:30 ET | Source: Karolinska Development AB (publ)

Karolinska Developments portföljbolag Aprea Therapeutics erhåller FDA Breakthrough Therapy Designation

STOCKHOLM, SVERIGE 30 januari 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget Aprea Therapeutics har erhållit Breakthrough Therapy Designation av det...
January 30, 2020 07:30 ET | Source: Karolinska Development AB (publ)

Karolinska Development's portfolio company Aprea Therapeutics receives FDA Breakthrough Therapy Designation

STOCKHOLM, SWEDEN – January 30, 2020. Karolinska Development (Nasdaq Stockholm: KDEV) announces today that its portfolio company Aprea Therapeutics has been granted Breakthrough Therapy Designation...
January 09, 2020 05:23 ET | Source: Karolinska Development AB (publ)

Karolinska Development har återbetalat resterande del av bolagets konvertibellån

STOCKHOLM, SVERIGE 9 januari 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att bolaget har genomfört de sista återbetalningarna på det konvertibellån som utfärdades 2015. ...
January 09, 2020 05:23 ET | Source: Karolinska Development AB (publ)

Karolinska Development has repaid the remaining part of the company's convertible loan

STOCKHOLM – January 9, 2020. Karolinska Development (Nasdaq Stockholm: KDEV) announces that the company has made the final repayments on the convertible loan issued in 2015. The convertible loan with...
December 30, 2019 02:00 ET | Source: Karolinska Development AB (publ)

Ändring av antal aktier och röster i Karolinska Development

STOCKHOLM den 30 december 2019. Antalet aktier av Serie B i Karolinska Development AB (Nasdaq Stockholm: KDEV) har ökat med totalt 32 476 086 som ett resultat av den slutliga delregistreringen av den...
December 30, 2019 02:00 ET | Source: Karolinska Development AB (publ)

Change of number of shares and votes in Karolinska Development

STOCKHOLM – December 30, 2019. The number of series B shares in Karolinska Development AB (Nasdaq Stockholm: KDEV) has increased by 32,476,086 shares as a result of the final partial registration of...
December 20, 2019 02:00 ET | Source: Karolinska Development AB (publ)

Karolinska Developments portföljbolag Umecrine Cognition erhåller Notice of Allowance från USPTO för patent som skyddar golexanolon

STOCKHOLM, SVERIGE 20 december 2019. Karolinska Development meddelar idag att dess portföljbolag Umecrine Cognition har erhållit besked från det amerikanska patentverket (USPTO) om ett preliminärt...
December 20, 2019 02:00 ET | Source: Karolinska Development AB (publ)

Karolinska Development´s portfolio company Umecrine Cognition announces Notice of Allowance from USPTO for a patent protecting lead compound golexanolone

STOCKHOLM, SWEDEN – December 20, 2019. Karolinska Development´s portfolio company Umecrine Cognition announces today that the United States Patent and Trademark Office (USPTO) has issued a Notice of...